Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.25
+0.10 (1.23%)
Feb 21, 2025, 4:00 PM EST - Market closed
Kura Oncology Employees
Kura Oncology had 142 employees as of December 31, 2023. The number of employees increased by 9 or 6.77% compared to the previous year.
Employees
142
Change (1Y)
9
Growth (1Y)
6.77%
Revenue / Employee
n/a
Profits / Employee
-$1,391,211
Market Cap
641.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
KURA News
- 3 days ago - Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 15 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies - Benzinga
- 17 days ago - Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs - GlobeNewsWire
- 6 weeks ago - Kura Oncology Announces Senior Executive Promotions - GlobeNewsWire
- 2 months ago - Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade) - Seeking Alpha
- 2 months ago - Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting - GlobeNewsWire
- 2 months ago - Kura Oncology to Host Virtual Investor Event on December 9, 2024 - GlobeNewsWire